• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Hydrafacial Announces Video Poster Abstract Presentation at the 2024 American Society for Dermatologic Surgery's Annual Meeting (ASDS): Hydrafacial enhances the outcomes of non-ablative laser and IPL treatments

    10/17/24 3:28:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care
    Get the next $SKIN alert in real time by email

    The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, announced today that a video poster abstract presentation on the efficacy and safety of Hydrafacial treatments combined with non-ablative fractional laser and intense pulsed light (IPL) full-face treatments will be featured at the American Society for Dermatologic Surgery (ASDS) meeting in Orlando, Florida from October 17-20, 2024.

    "This presentation on the clinical efficacy and safety of Hydrafacial treatments combined with non-ablative fractional laser or IPL full-face treatments represents a significant milestone for Hydrafacial," said Marla Beck, Chief Executive Officer of BeautyHealth. "Although Hydrafacial treatments are incredibly effective on their own, providers frequently report that they complement other aesthetic treatments perfectly. Now, scientific data will validate what providers have observed in their treatment rooms for years, introducing a new compelling Hydrafacial treatment protocol for those in the medical field."

    The following data will be presented:

    Title: A Randomized, Split-face, Prospective, Study to Assess the Efficacy and Safety of Hydradermabrasion after 1927nm Non-ablative Fractional Laser or Intense Pulsed Light Full-Face Treatments

    Presenting Author: Michael Abrouk, MD

    Format: Video Abstract

    • Highlights the synergistic effects of Hydrafacial when combined with non-ablative laser and IPL treatments.
    • Hydrafacial not only delivers exceptional results as a standalone treatment, but it also helps enhance the overall appearance of skin quality, hydration, and the outcomes of other advanced procedures.

    About The Beauty Health Company

    The Beauty Health Company (NASDAQ:SKIN) is a global category-creating company delivering millions of skin health experiences every year that help consumers reinvent their relationship with their skin, bodies, and self-confidence. Our brands are pioneers: Hydrafacial™ in hydradermabrasion, SkinStylus™ in microneedling, and Keravive™ in scalp health. Together, with our powerful global community of estheticians, partners, and consumers, we are personalizing skin health for all ages, genders, skin tones, and skin types. We are committed to being ever more mindful in how we conduct our business to positively impact our communities and the planet. Find a local provider at https://hydrafacial.com/find-a-provider/ and learn more at beautyhealth.com or LinkedIn.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20241017137338/en/

    Get the next $SKIN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Q&A

    New
    • What event will The Beauty Health Company present its research on Hydrafacial treatments?

      The Beauty Health Company announced that a video poster on Hydrafacial efficacy and safety will be presented at the ASDS meeting in Orlando.

    • What specific treatments will the presentation at the ASDS meeting focus on?

      The presentation will showcase the clinical efficacy and safety of Hydrafacial treatments combined with non-ablative fractional laser and IPL.

    • Who is the presenting spokesperson for The Beauty Health Company regarding the Hydrafacial presentation?

      Marla Beck, the CEO of BeautyHealth, stated that this presentation represents a significant milestone for Hydrafacial.

    • What key insights will be highlighted regarding Hydrafacial treatments in the presentation?

      The data presented will highlight how Hydrafacial enhances skin quality and complements other advanced aesthetic treatments.

    • What is the title of the study being presented regarding Hydrafacial treatments?

      The study is titled 'A Randomized, Split-face, Prospective, Study to Assess the Efficacy and Safety of Hydradermabrasion after 1927nm Non-ablative Fractional Laser or Intense Pulsed Light Full-Face Treatments.'

    Recent Analyst Ratings for
    $SKIN

    DatePrice TargetRatingAnalyst
    9/19/2025$3.50Buy
    Roth Capital
    11/15/2023$11.00 → $1.50Buy → Hold
    Jefferies
    11/14/2023$10.00 → $2.50Buy → Hold
    Canaccord Genuity
    11/14/2023Neutral → Underweight
    JP Morgan
    11/14/2023$12.00 → $2.00Overweight → Underweight
    Piper Sandler
    11/14/2023$9.00 → $2.50Outperform → Market Perform
    TD Cowen
    11/14/2023Buy → Hold
    The Benchmark Company
    11/14/2023Mkt Perform → Underperform
    Raymond James
    More analyst ratings

    $SKIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roth Capital initiated coverage on The Beauty Health Company with a new price target

    Roth Capital initiated coverage of The Beauty Health Company with a rating of Buy and set a new price target of $3.50

    9/19/25 8:39:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    The Beauty Health Company downgraded by Jefferies with a new price target

    Jefferies downgraded The Beauty Health Company from Buy to Hold and set a new price target of $1.50 from $11.00 previously

    11/15/23 7:13:27 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    The Beauty Health Company downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded The Beauty Health Company from Buy to Hold and set a new price target of $2.50 from $10.00 previously

    11/14/23 7:45:38 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Schaison Philippe was granted 57,692 shares (SEC Form 4)

    4 - Beauty Health Co (0001818093) (Issuer)

    11/17/25 4:14:30 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    Chief Revenue Officer Menezes Ronald covered exercise/tax liability with 46,426 shares, decreasing direct ownership by 4% to 1,074,705 units (SEC Form 4)

    4 - Beauty Health Co (0001818093) (Issuer)

    11/4/25 5:01:51 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    SEC Form 3 filed by new insider Schaison Philippe

    3 - Beauty Health Co (0001818093) (Issuer)

    11/3/25 4:11:41 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BeautyHealth Releases Third Annual Skintuition Report

    LONG BEACH, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today released Volume Three of its Skintuition Report, an annual deep dive into the forces shaping modern skin health. This year's report uncovers the most significant consumer-driven shifts of 2025, identifies the trends poised to define aesthetics in 2026, and offers new insight into how people are approaching longer-term skin health and regeneration. Designed to decode the state of skin health today and where it's headed, the report integrates science, innovation, clinical data, cultural trends, and provider perspectives to reveal why skin regeneration, rat

    12/4/25 9:15:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    BeautyHealth Reports Third Quarter 2025 Financial Results

    LONG BEACH, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the third quarter ended September 30, 2025 ("Q3 2025"). "Our third-quarter results reflect disciplined execution and the continued strengthening of BeautyHealth's foundation," said BeautyHealth President and CEO, Pedro Malha. "Revenue of $70.7 million and Adjusted EBITDA of $8.9 million exceeded the top end of our guidance range, supported by ongoing operational efficiency. While device sales remained under pressure, the recurring consumables business continued to demonstrate resilience an

    11/6/25 4:05:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    BeautyHealth Appoints Philippe Schaison, PharmaD, to Board of Directors

    LONG BEACH, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The BeautyHealth Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of global aesthetics leader, Philippe Schaison, PharmaD, to its Board of Directors, effective as of October 30, 2025. Dr. Schaison has spent over 20 years leading organizations across the global aesthetics, biotech, and consumer health industries. He currently serves as Chief Executive Officer and a director of Soltégo, Inc., a bio-cosmetic company. Previously, Dr. Schaison was Chief Executive Officer NA of Syneron Candela, President of Allergan Aesthetics, and held senior leadership roles at Clarins, Johnson & Johnson, and L'Oré

    11/3/25 4:05:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    SEC Filings

    View All

    SEC Form 144 filed by The Beauty Health Company

    144 - Beauty Health Co (0001818093) (Subject)

    12/5/25 1:04:28 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by The Beauty Health Company

    10-Q - Beauty Health Co (0001818093) (Filer)

    11/6/25 5:17:26 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    The Beauty Health Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Beauty Health Co (0001818093) (Filer)

    11/6/25 4:10:47 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman Saunders Brent L bought $43,686 worth of shares (40,450 units at $1.08), increasing direct ownership by 0.69% to 5,921,769 units (SEC Form 4)

    4 - Beauty Health Co (0001818093) (Issuer)

    8/13/24 5:00:11 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Leadership Updates

    Live Leadership Updates

    View All

    BeautyHealth Appoints Philippe Schaison, PharmaD, to Board of Directors

    LONG BEACH, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The BeautyHealth Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of global aesthetics leader, Philippe Schaison, PharmaD, to its Board of Directors, effective as of October 30, 2025. Dr. Schaison has spent over 20 years leading organizations across the global aesthetics, biotech, and consumer health industries. He currently serves as Chief Executive Officer and a director of Soltégo, Inc., a bio-cosmetic company. Previously, Dr. Schaison was Chief Executive Officer NA of Syneron Candela, President of Allergan Aesthetics, and held senior leadership roles at Clarins, Johnson & Johnson, and L'Oré

    11/3/25 4:05:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    The Beauty Health Company Names Pedro Malha President and Chief Executive Officer

    Global Healthcare and Medical Device Executive with More Than 20 Years of Experience Assumes Role Effective October 1 Marla Beck Steps Down, With BeautyHealth Prepared for Its Next Phase of Growth LONG BEACH, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of Pedro Malha as President and Chief Executive Officer, effective October 1, 2025. He succeeds Marla Beck, who is stepping down as President and CEO effective September 30, 2025, and will remain in an advisory role. Brent Saunders, Chairman of the Board, stated, "Pedro is an accomplished leader with broad industry experience at lea

    9/30/25 4:30:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    The Beauty Health Company Strengthens Commercial Leadership Team with Chief Revenue Officer and Chief Marketing Officer Appointments

    The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of two accomplished industry executives to its commercial leadership team. Ron Menezes will join Beauty Health as Chief Revenue Officer and Carrie Caulkins will join the Company as Chief Marketing Officer, effective October 15, 2024, with both reporting to the Company's Chief Executive Officer, Marla Beck. Mr. Menezes assumes his new role from Dan ("Doc") Watson, who is leaving Beauty Health and will assist with the transition through year-end. Ms. Caulkins fills an open position. Marla Beck commented on the appointments, "We are thrilled to welcome Ron and Carrie to the executive t

    10/15/24 4:10:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Financials

    Live finance-specific insights

    View All

    BeautyHealth Reports Third Quarter 2025 Financial Results

    LONG BEACH, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the third quarter ended September 30, 2025 ("Q3 2025"). "Our third-quarter results reflect disciplined execution and the continued strengthening of BeautyHealth's foundation," said BeautyHealth President and CEO, Pedro Malha. "Revenue of $70.7 million and Adjusted EBITDA of $8.9 million exceeded the top end of our guidance range, supported by ongoing operational efficiency. While device sales remained under pressure, the recurring consumables business continued to demonstrate resilience an

    11/6/25 4:05:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    BeautyHealth to Report Third Quarter 2025 Financial Results on November 6, 2025

    LONG BEACH, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report third quarter 2025 financial results after market close on Thursday, November 6, 2025. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the Company's investor relations website at https://investors.beautyhealth.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure InformationThe Beauty Health Company announc

    10/23/25 10:00:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    BeautyHealth Reports Second Quarter 2025 Financial Results

    Raises guidance on strong execution and disciplined cost management Advances science-backed innovation with successful launch of the HydraFillic with Pep9™ Booster LONG BEACH, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the second quarter ended June 30, 2025 ("Q2 2025"). "Momentum continued to build in the second quarter, as BeautyHealth delivered another strong performance aligned with our strategic transformation goals," said BeautyHealth CEO Marla Beck. "We exceeded revenue and Adjusted EBITDA expectations and raised the full year ou

    8/7/25 4:05:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

    SC 13G/A - Beauty Health Co (0001818093) (Subject)

    11/14/24 4:16:27 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

    SC 13G/A - Beauty Health Co (0001818093) (Subject)

    11/14/24 11:27:23 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

    SC 13G/A - Beauty Health Co (0001818093) (Subject)

    11/14/24 11:03:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care